B
Bertrand Baujat
Researcher at University of Paris
Publications - 95
Citations - 2794
Bertrand Baujat is an academic researcher from University of Paris. The author has contributed to research in topics: Cancer & Radiation therapy. The author has an hindex of 19, co-authored 85 publications receiving 2284 citations. Previous affiliations of Bertrand Baujat include Institut Gustave Roussy & University of Manchester.
Papers
More filters
Journal ArticleDOI
Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients
Bertrand Baujat,Hélène Audry,Jean Bourhis,Anthony T.C. Chan,Haluk Onat,Daniel T.T. Chua,Dora L.W. Kwong,Muhyi Al-Sarraf,Kwan Hwa Chi,Masato Hareyama,Sing Fai Leung,Kullathorn Thephamongkhol,Jean Pierre Pignon +12 more
TL;DR: Chemotherapy led to a small, but significant, benefit for overall survival and event-free survival when chemotherapy was administered concomitantly with RT.
Journal ArticleDOI
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
Pierre Blanchard,Bertrand Baujat,Victoria Holostenco,Abderrahmane Bourredjem,Charlotte Baey,Jean Bourhis,Jean-Pierre Pignon +6 more
TL;DR: The benefit of the addition of chemotherapy to locoregional treatment is consistent in all tumour locations of HNSCC, with hazard ratios between 0.87 and 0.88 and the higher benefit of concomitant schedule was demonstrated only for oropharyngeal and laryngeAl tumours but this may be only a consequence of a lack of power.
Journal ArticleDOI
A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.
TL;DR: The proposed graphical method identifies trials that account for most of the heterogeneity without having to explore all possible sources of heterogeneity by subgroup analyses and can be applied to identify types of patients that explain heterogeneity in the treatment effect.
Journal ArticleDOI
Individual patients' data meta-analyses in head and neck cancer
TL;DR: This database provided a unique tool to evaluate long-term effects of chemotherapy and altered fractionated radiotherapy in head and neck cancer and allowed the oncological community to obtain a reliable characterization of the magnitude of the treatment benefits in this type of cancer.
Journal ArticleDOI
Hyperfractionated or accelerated radiotherapy for head and neck cancer.
Bertrand Baujat,Jean Bourhis,Pierre Blanchard,Jens Overgaard,Kian K. Ang,M.I. Saunders,Aurélie Le Maître,Jacques Bernier,Jean Claude Horiot,Emilie Maillard,Thomas F. Pajak,Michael Poulsen,Abderrahmane Bourredjem,Brian O'Sullivan,W. Dobrowsky,Hliniak Andrzej,Krzystof Skladowski,John Hay,Luiz H. J. Pinto,Karen K. Fu,Carlo Fallai,Richard Sylvester,Jean Pierre Pignon +22 more
TL;DR: Comparison of the different types of altered radiotherapy suggests that hyperfractionation provides the greatest benefit, which was particularly efficient in reducing local failure, whereas the benefit on nodal control was less pronounced.